Leverage Partners Absolute Return Fund SPC’s West Pharmaceutical WST Stock Holding History

Leverage Partners Absolute Return Fund SPC’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-3,000	Closed	-$1.23M	–	82
2022 Q1	$1.23M	Hold	3,000	–	–	0.88%	40
2021 Q4	$1.41M	Hold	3,000	–	–	0.8%	48
2021 Q3	$1.27M	Sell	3,000 -13	-0.4%	-$5.48K	1.22%	28
2021 Q2	$1.08M	Buy	3,013 +13	+0.4%	+$4.29K	0.75%	50
2021 Q1	$845	Hold	3,000	–	–	0.62%	52
2020 Q4	$849K	Buy	+3,000	New	+$842K	0.68%	55

Other funds holding WST

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Leverage Partners Absolute Return Fund SPC's WST Position: Q2 2022 in Review

Leverage Partners Absolute Return Fund SPC sold out of West Pharmaceutical (WST) in Q2 2022, closing a stake of 3,000 shares — an estimated $1.23M sold.

Leverage Partners Absolute Return Fund SPC first reported a position in WST in Q4 2020 and held it in 6 quarters. The position peaked at $1.41M in Q4 2021. 655 funds tracked by Wall St. Rank hold WST as of Q2 2022.

Leverage Partners Absolute Return Fund SPC reported no remaining West Pharmaceutical position as of Q2 2022 after selling out during the quarter.
Leverage Partners Absolute Return Fund SPC sold 3,000 West Pharmaceutical shares in Q2 2022, an estimated $1.23M.
Leverage Partners Absolute Return Fund SPC first reported a position in West Pharmaceutical in Q4 2020 and held it in 6 quarters.
Leverage Partners Absolute Return Fund SPC's West Pharmaceutical position peaked at $1.41M in Q4 2021.
655 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2022.

Based on Leverage Partners Absolute Return Fund SPC's 13F filing for Q2 2022, filed 5 Aug 2022.